MedTrace Logo

Clinical Application of Portable Intelligent Multi Joint Isokinetic Training and Evaluation System Technology

NCT06153992 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-12-01

No results posted yet for this study

Summary

The goal of this clinical trial is to compare in describeparticipant population. The main question it aims to answer is:By using intelligent portable isokinetic tester and traditional isokinetic tester, isokinetic knee flexor and extensor muscles of stroke patients with hemiplegia were trained respectively, so as to observe and compare the effects of the two treatment methods. In addition, the therapeutic effect of the above two treatments was compared with that of exercise therapy alone. Participants will be divided into three groups: control group, intelligent isokinetic treatment group, and traditional isokinetic treatment group. Participants of both the control group and the two treatment groups received exercise therapy. On the basis of exercise therapy, participants of the intelligent isokinetic treatment group used the intelligent portable isokinetic tester to train the affected knee flexion and extensor muscle, while the participants of traditional isokinetic treatment group used the intelligent portable isokinetic tester to train the affected knee flexion and extensor muscle.

Conditions

  • Stroke
  • Hemiplegia
  • Rehabilitation; Tobacco Use
  • Physical Disability

Interventions

DEVICE

Intelligent portable isokinetic muscle strength test training

The isokinetic training of knee flexors and extensors was carried out by using intelligent portable isokinetic muscle strength test training system

DEVICE

isokinetic muscle strength test training

The isokinetic training of knee flexors and extensors was carried out by using isokinetic muscle strength test training system

OTHER

without test training

Treatment was performed without using any isokinetic muscle strength test training system

Sponsors & Collaborators

  • Ran Shi

    lead OTHER

Principal Investigators

  • Sanyuan Hu, doctor · Qianfoshan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-01
Completion
2024-12-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06153992 on ClinicalTrials.gov